Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IBBJ Defiance Nasdaq Junior Biotechnology ETF (IBBJ) Price, Holdings, & News Add Share Share Stock Analysis Stock Analysis About Defiance Nasdaq Junior Biotechnology ETF (NASDAQ:IBBJ) 30 days 90 days 365 days Advanced Chart Get IBBJ alerts:Sign Up Key Stats Today's Range$29.87▼$29.8750-Day Range$29.87▼$29.9452-Week Range$27.85▼$41.45VolumeN/AAverage Volume4,475 shsMarket Capitalization$7.47 millionAssets Under Management$2.54 millionDividend Yield1.00%Net Expense Ratio0.45%Aggregate RatingN/A ETF OverviewRead More… Defiance Nasdaq Junior Biotechnology ETF ExpensesTypeIBBJEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.56%0.51%0.53%Other Expenses0.00%0.50%0.47%0.53%Total Expense0.45%0.72%0.67%0.71%Fee Waiver0.00%-0.50%-0.32%-0.56%Net Expense0.45%0.62%0.60%0.60% Receive IBBJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Defiance Nasdaq Junior Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBJ ETF News HeadlinesLLYX Defiance Daily Target 2X Long LLY ETFSeptember 18, 2024 | seekingalpha.comSMCX Defiance Daily Target 2X Long SMCI ETFAugust 30, 2024 | seekingalpha.comBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.February 24, 2025 | Brownstone Research (Ad)Nautilus Biotechnology Stock (NASDAQ:NAUT) Insider TradesFebruary 21, 2024 | benzinga.comiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.1239December 21, 2023 | msn.comBlackRock Institutional Trust Company N.A. - iShares Biotechnology ETFJuly 24, 2023 | money.usnews.comSee More Headlines IBBJ ETF - Frequently Asked Questions What other stocks do shareholders of Defiance Nasdaq Junior Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Defiance Nasdaq Junior Biotechnology ETF investors own include ARK Genomic Revolution ETF (ARKG), Plug Power (PLUG), Alkaline Water (WTER), Albemarle (ALB), Alpha Lithium (APHLF), ARK Fintech Innovation ETF (ARKF) and Ameriwest Lithium (AWLID). Fund Details IssuerDefiance ETFs Fund NameDefiance Nasdaq Junior Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBJ Inception Date8/4/2020 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Junior Biotechnology Index CategoryHealth Care FocusSector Development LevelBlended Develoment RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$2.54 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorDefiance ETFs, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares250,000BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report IBBJ Sector ExposureIBBJ Industry Exposure This page (NASDAQ:IBBJ) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredShocking new Trump video releasedThe 10 Stocks Guaranteed To Boom With Trump Back In Office I’m not talking about Tesla or Palantir… Trum...Porter & Company | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Nasdaq Junior Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Defiance Nasdaq Junior Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
